@ARTICLE{
author={Pastores Gregory M,Shankar Suma P,Petakov Milan S,Giraldo Pilar,Rosenbaum Hanna,Amato Dominick J,Szer Jeffrey,Chertkoff Raul,Brill-Almon Einat,Zimran Ari},
year={2016},
title={Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase},
journal={AMERICAN JOURNAL OF HEMATOLOGY},
volume={91},
number={7},
pages={661-665},
document_type={Article},
} 

@ARTICLE{
author={Zimran Ari,Duran Gloria,Mehta Atul,Giraldo Pilar,Rosenbaum Hanna,Giona Fiorina,Amato Dominick J,Petakov Milan S,Munoz Eduardo Terreros,Solorio-Meza Sergio Eduardo,Cooper Peter A,Varughese Sheeba,Chertkoff Raul,Brill-Almon Einat},
year={2016},
title={Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naive patients with Gaucher disease},
journal={AMERICAN JOURNAL OF HEMATOLOGY},
volume={91},
number={7},
pages={656-660},
document_type={Article},
} 

@ARTICLE{
author={Pastores Gregory M,Petakov Milan S,Giraldo Pilar,Rosenbaum Hanna,Szer Jeffrey,Deegan Patrick B,Amato Dominick J,Mengel Eugen,Tan Ee Shien,Chertkoff Raul,Brill-Almon Einat,Zimran Ari},
year={2014},
title={A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={53},
number={4},
pages={253-260},
document_type={Article},
} 

@ARTICLE{
author={van Dussen Laura,Zimran An,Akkerman EM,Aerts JMFG,Petakov Milan S,Elstein Deborah,Rosenbaum H,Aviezer David,Brill-Almon Einat,Chertkoff Raul,Maas M,Hollak CEM},
year={2013},
title={Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={50},
number={3},
pages={206-211},
document_type={Article},
}